SINOPHARM TECH (08156): Public float is approximately 24.95%

18:00 16/09/2026

SINOPHARM TECH (08156) announced that due to the Company's inadvertent failure regarding the public float requirement, as at the date of this announcement, the Company's public float is approximately 24.95%, which is below the minimum public float requirement of 25.0% as prescribed under Rule 17.37B(1) of the Rules Governing the Listing of Securities on GEM of The Stock Exchange of Hong Kong Limited.

SINOPHARM TECH (08156) announced that due to an inadvertent mistake by the Company regarding the public float requirement, as of the date of this announcement, the Company's public float is approximately 24.95%, which is below the minimum public float requirement of 25.0% as stipulated under Rule 17.37B(1) of the GEM Listing Rules of The Stock Exchange of Hong Kong Limited.

MNSO (09896) repurchased 1.822 million shares for HKD 31.8161 million on September 16.

Sanbo Hospital Management (301293.SZ)'s controlling shareholder and actual controller intend to donate part of the company's shares without compensation.

CENTRAL CHINA (00832) August property contracted sales amounted to RMB 572 million, a year-on-year decrease of 12.9%.

MNSO (09896) repurchased 1.822 million shares for HKD 31.8161 million on September 16.

Sanbo Hospital Management (301293.SZ)'s controlling shareholder and actual controller intend to donate part of the company's shares without compensation.

CENTRAL CHINA (00832) August property contracted sales amounted to RMB 572 million, a year-on-year decrease of 12.9%.